Search - tctmd.com

Displaying 741 - 760 of 1233

Sort: Relevancy | Date

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Daily News

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Yael L. Maxwell

May 09, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Industry News

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

May 01, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Industry News

Cook Medical Provides Patient-Level Paclitaxel Data From Randomised Control Trial

April 19, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Featured Fellow

Philipp Wiesner, MD

Yael L. Maxwell

April 01, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News EHRA 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

Todd Neale

March 25, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

Advertisement

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Cook Medical Provides Patient-Level Paclitaxel Data From Randomised Control Trial

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Philipp Wiesner, MD

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content